Hexaware Technologies Share Price Rise 6.46% to ₹578 After Announcement of CareInsight Partnership

Hexaware Technologies Ltd (NSE: HEXT) gained 6.46% to ₹578.00 as of 12:18 PM IST on 13 February, compared with the previous close of ₹542.95, according to exchange data. The stock advanced ₹35.05 during the session so far, recovering after recent weakness over the past month.

The buying interest followed a regulatory disclosure made after market hours on 12 February regarding a strategic partnership in the healthcare technology segment.

Why Hexaware Technologies Share Price Rose

Hexaware Technologies informed the exchange on 12 February 2026 that it had entered into a strategic partnership with CareInsight to accelerate AI-driven healthcare transformation, as per the company’s regulatory filing and press release.

According to the regulatory filing, the collaboration will integrate CareInsight’s AI-native platforms, including careassistant.ai™, carewallet.ai™, voice assist, and health3d.ai™, into Hexaware’s AI-powered healthcare offerings. The partnership is aimed at enabling production-grade AI deployment at scale, with a regulatory-ready architecture for healthcare organisations.

The stock’s rebound also comes after a 21.45% decline over the past month, during which it fell ₹157.55 month-on-month to ₹577.05 as of 12:19 PM IST on 13 February, based on exchange data.

Hexaware Technologies Stock Performance Snapshot

As of 12:18 PM IST on 13 February, Hexaware Technologies traded at ₹578.00, up 6.46% from the previous close of ₹542.95.

The stock opened at ₹530.00 and has traded between ₹521.55 and ₹589.70 so far during the session. Market capitalisation stood at approximately ₹35.16K crore, with a price-to-earnings (P/E) ratio of 26.09. The 52-week high and low were ₹900.00 and ₹521.55, respectively.

What this Means for Investors

The announced partnership strengthens Hexaware’s positioning in AI-led healthcare transformation, a segment focused on digital, automation, and cloud-enabled service delivery. As per the company’s disclosure, the collaboration is designed to support integrated data flows, operational decision-making, and outcome-based transformation across healthcare payers and providers.

Investors may monitor subsequent disclosures for revenue contribution, client wins, or margin implications arising from this partnership.

Management Commentary

Management commentary in the press release quoted Shantanu Baruah, President & Global Head – Healthcare, Life Sciences & Insurance, Hexaware, stating that the partnership aims to help organisations operationalise AI at scale and accelerate value-based care. Raj Kadam, CEO of CareInsight, said the collaboration would help move from AI pilots to production-scale deployment.

Hexaware Technologies rose 6.46% to ₹578.00 as of 12:18 PM IST on 13 February, following its exchange disclosure of a strategic partnership with CareInsight to accelerate AI-driven healthcare transformation. The collaboration focuses on embedding AI-native healthcare platforms into Hexaware’s offerings to enable production-scale deployment. The stock’s move reflects a positive market response to the regulatory announcement, after a period of recent monthly decline.

References

• https://www.bseindia.com/xml-data/corpfiling/AttachLive/14b264e2-442a-4d39-b44a-78d4171341bc.pdf
• https://nsearchives.nseindia.com/corporate/HEXAWARETECH_12022026213713_Final.pdf